Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation
用于血清分析和单克隆抗体分离的抗原特异性探针的设计
基本信息
- 批准号:8556160
- 负责人:
- 金额:$ 9.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdsorptionAntibodiesAntibody FormationAntigensB-LymphocytesBindingBioinformaticsBiologicalBiological AssayComputational BiologyDevelopmentElementsEpitopesEvaluationGenesGoalsHIV-1Immune systemIndividualInfectionPatientsPlayProcessProteinsRoleSerologic testsSerumSolutionsSpecificityStructureSurfaceTechniquesTherapeuticVaccinesVariantbasecomputerized toolsdesignenv Glycoproteinsflexibilityinsightneutralizing antibodynext generationnovelphysical propertyresearch studyresponsestructural biologytool
项目摘要
An understanding of the serum responses of both HIV-1-infected individuals and vaccines is necessary for the development of an effective HIV-1 vaccine. Perhaps the most important biological aspect of a serum response is its neutralizing activity, with a close second being a compendium of its antigenic recognition. We will utilize the tools of structural and computational biology to develop probes to assist in the evaluation of the neutralizing activity of sera, and to decipher the HIV-1 elements recognized by both binding and neutralizing antibodies. Further, these probes will be used for the selection and isolation of B-cells so that their antibody gene loci can be sequenced, enabling the in-depth characterization of secreted antibodies. These capabilities are expected to enhance our understanding of how a broadly neutralizing antibody response develops during the course of infection and also of how the humoral immune system targets vulnerable regions on the HIV-1 Env glycoprotein.
The tools of computational design allow for the manipulation of both the surface of a protein as well as its interior. Surface manipulation allows for a precise control of antigenicity, whereas interior manipulation allows for physical properties of flexibility and stability to be altered, thereby modulating surface antigencity. Together these tools should allow for a precise understanding of elicited serum responses. Such an understanding should facilitate the iterative structure-based improvement of immunogens.
The next-generation sequencing technique, 454 pyrosequencing, allows hundreds of thousands of antibody sequences to be obtained directly from patient sera, thus enabling quantitative analysis of serum response, better understanding of antibody maturation process, and identification of broadly neutralizing antibodies. Due to the natural variation of antibody sequences and inherent sequencing errors, novel bioinformatics techniques have to be developed for antibodyome analysis. These techniques will play a critical role in sera analysis and antibody identification. Identified antibodies can represent natural solutions to antibody optimization, which has potential implications for therapeutic and/or passive transfer studies.
了解 HIV-1 感染者和疫苗的血清反应对于开发有效的 HIV-1 疫苗是必要的。也许血清反应最重要的生物学方面是其中和活性,紧随其后的是其抗原识别概要。我们将利用结构和计算生物学工具开发探针,以协助评估血清的中和活性,并破译结合抗体和中和抗体识别的HIV-1元件。此外,这些探针将用于选择和分离 B 细胞,以便对其抗体基因位点进行测序,从而能够深入表征分泌的抗体。这些能力预计将增强我们对感染过程中广泛中和抗体反应如何发展的理解,以及体液免疫系统如何针对 HIV-1 Env 糖蛋白上的脆弱区域的理解。
计算设计工具允许操纵蛋白质的表面及其内部。表面操作可以精确控制抗原性,而内部操作可以改变柔韧性和稳定性的物理特性,从而调节表面抗原性。这些工具一起应该可以准确地理解引发的血清反应。这种理解应该有助于免疫原的基于迭代结构的改进。
新一代测序技术,454焦磷酸测序,可以直接从患者血清中获得数十万个抗体序列,从而能够定量分析血清反应,更好地了解抗体成熟过程,并鉴定广泛中和抗体。由于抗体序列的自然变异和固有的测序错误,必须开发新的生物信息学技术用于抗体组分析。这些技术将在血清分析和抗体鉴定中发挥关键作用。已鉴定的抗体可以代表抗体优化的自然解决方案,这对治疗和/或被动转移研究具有潜在影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter D Kwong其他文献
Peter D Kwong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter D Kwong', 18)}}的其他基金
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design
CAPRISA HIV-1 中和抗体:利用个体发育进行免疫原设计
- 批准号:
9197956 - 财政年份:2015
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
10497779 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
8336700 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Neutralization Mechanisms Of Anti-HIV-1 Monoclonal Antibodies
抗 HIV-1 单克隆抗体的中和机制
- 批准号:
8556097 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
8946617 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
相似国自然基金
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
- 批准号:32370967
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
- 批准号:22307081
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于淬灭抗体的重金属镉快速定量免疫分析
- 批准号:22306074
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
- 批准号:82303723
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
HLA-DQ在实体器官移植中的免疫原性和致病性
- 批准号:
10658665 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Utilizing Dendritic Cell Biology to Characterize the Innate Immune Response to Blood Coagulation Proteins
利用树突状细胞生物学来表征对凝血蛋白的先天免疫反应
- 批准号:
10580074 - 财政年份:2020
- 资助金额:
$ 9.9万 - 项目类别:
Humoral response to viral and self-antigens in HIV infection
HIV感染中对病毒和自身抗原的体液反应
- 批准号:
8602680 - 财政年份:2013
- 资助金额:
$ 9.9万 - 项目类别:
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
慢性淋巴细胞白血病靶向治疗的给药策略
- 批准号:
8478334 - 财政年份:2013
- 资助金额:
$ 9.9万 - 项目类别:
Evolution of glycan-reactive broadly neutralizing anti-v2 antibodies in HIV infec
HIV感染者中聚糖反应性广泛中和抗v2抗体的进化
- 批准号:
8542060 - 财政年份:2013
- 资助金额:
$ 9.9万 - 项目类别: